Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors
Apolo, Andrea B, Nadal, Rosa, Girardi, Daniel M, Niglio, Scot A, Ley, Lisa, Cordes, Lisa M, Steinberg, Seth M, Sierra Ortiz, Olena, Cadena, Jacqueline, Diaz, Carlos, Mallek, Marissa, Davarpanah, Nicole N, Costello, Rene, Trepel, Jane B, Lee, Min-Jung, Merino, Maria J, Bagheri, Mohammad Hadi, Monk, Paul, Figg, William D, Gulley, James L, Agarwal, Piyush K, Valera, Vladimir, Chalfin, Heather J, Jones, Jennifer, Streicher, Howard, Wright, John J, Ning, Yangmin M, Parnes, Howard L, Dahut, William L, Bottaro, Donald P, Lara, Jr, Primo N, Saraiya, Biren, Pal, Sumanta K, Stein, Mark N, Mortazavi, Amir
Published in Journal of clinical oncology (01.11.2020)
Published in Journal of clinical oncology (01.11.2020)
Get full text
Journal Article
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial
Apolo, Andrea B, Nadal, Rosa, Tomita, Yusuke, Davarpanah, Nicole N, Cordes, Lisa M, Steinberg, Seth M, Cao, Liang, Parnes, Howard L, Costello, Rene, Merino, Maria J, Folio, Les R, Lindenberg, Liza, Raffeld, Mark, Lin, Jeffrey, Lee, Min-Jung, Lee, Sunmin, Alarcon, Sylvia V, Yuno, Akira, Dawson, Nancy A, Allette, Kimaada, Roy, Arpita, De Silva, Dinuka, Lee, Molly M, Sissung, Tristan M, Figg, William D, Agarwal, Piyush K, Wright, John J, Ning, Yangmin M, Gulley, James L, Dahut, William L, Bottaro, Donald P, Trepel, Jane B
Published in The lancet oncology (01.08.2020)
Published in The lancet oncology (01.08.2020)
Get full text
Journal Article
Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary
NING, Yangmin M, PIERCE, William, QI LIU, GHOSH, Debasis, COTTRELL, Christy L, LEIGHTON, John, SRIDHARA, Rajeshwari, IBRAHIM, Amna, JUSTICE, Robert, PAZDUR, Richard, MAHER, V. Ellen, KARURI, Stella, TANG, Sheng-Hui, CHIU, Haw-Jyh, PALMBY, Todd, ZIRKELBACH, Jeanne Fourie, MARATHE, Dhananjay, MEHROTRA, Nitin
Published in Clinical cancer research (15.11.2013)
Published in Clinical cancer research (15.11.2013)
Get full text
Journal Article
Tumor progression versus bone scan “flare” in new lesions detected on early bone scans in patients with chemo-naïve metastatic castration resistant prostate cancer (mCRPC) treated with placebo or enzalutamide
Ning, Yangmin M., Chen, Clara, Maher, Virginia Ellen, Xu, James Xunhai, Kim, Geoffrey, Pazdur, Richard
Published in Journal of clinical oncology (10.01.2016)
Published in Journal of clinical oncology (10.01.2016)
Get full text
Journal Article
Cabozantinib and peripheral immunity in advanced urothelial carcinoma: Final results from an open-label, phase II trial
Apolo, Andrea B., Nadal, Rosa, Tomita, Yusuke, Davarpanah, Nicole N., Cordes, Lisa M., Steinberg, Seth M., Cao, Liang, Parnes, Howard L., Costello, Rene, Merino, Maria J., Folio, Les R., Lindenberg, Liza, Raffeld, Mark, Lin, Jeffrey, Lee, Min-Jung, Lee, Sunmin, Alarcon, Sylvia V., Yuno, Akira, Dawson, Nancy A., Allette, Kimaada, Roy, Arpita, De Silva, Dinuka, Lee, Molly M., Sissung, Tristan M., Figg, William D., Agarwal, Piyush K., Wright, John J., Ning, Yangmin M., Gulley, James L., Dahut, William L., Bottaro, Donald P., Trepel, Jane B.
Published in The lancet oncology (06.07.2020)
Published in The lancet oncology (06.07.2020)
Get full text
Journal Article
A phase I study of cabozantinib plus nivolumab (CaboNivo) and cabonivo plus ipilimumab (CaboNivoIpi) in patients (pts) with refractory metastatic (m) urothelial carcinoma (UC) and other genitourinary (GU) tumors
Apolo, Andrea B., Mortazavi, Amir, Stein, Mark N., Davarpanah, Nicole N., Nadal, Rosa Maria, Parnes, Howard L., Ning, Yangmin M., Francis, Deneise C, Cordes, Lisa M, Berniger, Marilise Anne, Steinberg, Seth M., Agarwal, Piyush K., Bagheri, Mohammadhadi H., Nanda, Swati, Monk, Paul, Lancaster, Tiffany, Moore, Tina, Costello, Rene, Bottaro, Donald P., Pal, Sumanta K.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
A phase I study of cabozantinib plus nivolumab (CaboNivo) and ipilimumab (CaboNivoIpi) in patients (pts) with refractory metastatic urothelial carcinoma (mUC) and other genitourinary (GU) tumors
Apolo, Andrea B., Mortazavi, Amir, Stein, Mark N., Pal, Sumanta K., Davarpanah, Nicole N., Parnes, Howard L., Ning, Yangmin M., Francis, Deneise C, Cordes, Lisa M, Monk, Paul, Lancaster, Tiffany, Costello, Rene, Nanda, Swati, Bottaro, Donald P., Wright, John Joseph, Streicher, Howard, Steinberg, Seth M., Berninger, Marilise, Lindenberg, Liza, Dahut, William L.
Published in Journal of clinical oncology (20.02.2017)
Published in Journal of clinical oncology (20.02.2017)
Get full text
Journal Article
Special protocol assessments: 10 years of experience in FDA’s Office of Hematology and Oncology Products
Maher, Virginia Ellen, Kacuba, Alice, Ning, Yangmin M., Murgo, Anthony J., Ibrahim, Amna, Farrell, Ann T., Keegan, Patricia, Justice, Robert L., Pazdur, Richard
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
FDA breakthrough therapy designation of oncology products: The first-year experience
Ning, Yangmin M., Kim, Tamy, Maher, Virginia Ellen, Ibrahim, Amna, Murgo, Anthony J., Farrell, Ann T., Keegan, Patricia, Justice, Robert L., Pazdur, Richard
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
A phase II study of cabozantinib in patients (pts) with relapsed or refractory metastatic urothelial carcinoma (mUC)
Apolo, Andrea B., Parnes, Howard L., Francis, Deneise C, Cordes, Lisa M, Berninger, Marilise, Lamping, Elizabeth, Costello, Rene, Trepel, Jane B., Merino, Maria J, Folio, Les, Lindenberg, Maria Liza, Figg, William Douglas, Steinberg, Seth M., Wright, John Joseph, Madan, Ravi Amrit, Ning, Yangmin M., Gulley, James L., Bottaro, Donald P., Dahut, William L., Agarwal, Piyush K.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Use of supportive measures to improve outcome and decrease toxicity in docetaxel-based antiangiogenesis combinations in metastatic castrate resistant prostate cancer (mCRPC)
Karzai, Fatima H., Madan, Ravi Amrit, Apolo, Andrea Borghese, Ning, Yangmin M., Parnes, Howard L., Arlen, Philip M., Beatson, Melony A., Harold, Nancy, Couvillon, Anna, Wright, John Joseph, Chen, Clara, Dawson, Nancy Ann, Gulley, James L., Figg, William Douglas, Dahut, William L.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Use of supportive measures to improve outcome and decrease toxicity in docetaxel-based antiangiogenesis combinations
Karzai, Fatima H., Adesunloye, Bamidele, Ning, Yangmin M., Madan, Ravi Amrit, Gulley, James L., Apolo, Andrea Borghese, Beatson, Melony A., Couvillon, Anna, Harold, Nancy, Parnes, Howard L., Arlen, Philip M., Wright, John Joseph, Chen, Clara, Dawson, Nancy Ann, Figg, William Douglas, Dahut, William L.
Published in Journal of clinical oncology (20.02.2013)
Published in Journal of clinical oncology (20.02.2013)
Get full text
Journal Article
Dual antiangiogenic therapy using lenalidomide and bevacizumab with docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC)
Adesunloye, Bamidele, Huang, Xuan, Ning, Yangmin M., Madan, Ravi A., Gulley, James L., Beatson, Melony, Kluetz, Paul Gustav, Adelberg, David E., Arlen, Philip M., Parnes, Howard L., Mulquin, Marcia, Steinberg, Seth M., Wright, John Joseph, Trepel, Jane B., Dawson, Nancy Ann, Chen, Clara, Bassim, Carol, Apolo, Andrea Borghese, Figg, William Douglas, Dahut, William L.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Phase II trial of bevacizumab and lenalidomide with docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC)
Adesunloye, Bamidele, Huang, Xuan, Ning, Yangmin M., Madan, Ravi A., Gulley, James L., Beatson, Melony, Kluetz, Paul Gustav, Adelberg, David, Arlen, Philip M., Parnes, Howard L., Mulquin, Marcia, Steinberg, Seth M., Wright, John Joseph, Trepel, Jane B., Dawson, Nancy Ann, Chen, Clara, Apolo, Andrea Borghese, Figg, William Douglas, Dahut, William L.
Published in Journal of clinical oncology (10.02.2012)
Published in Journal of clinical oncology (10.02.2012)
Get full text
Journal Article